About Galen Growth

A decade of intelligence—and still moving digital health forward

Galen Growth is an active digital health intelligence company founded in Singapore. We bring structure, evidence, and comparability to a global market that continues to evolve.

The beginning

From fragmented information to a research foundation

In November 2015, Julien de Salaberry, Nawal Roy, Snehal Patel, Ronald Ling, and Jeremy Sun came together around a shared observation: healthcare leaders were being asked to make digital health decisions without a consistent market definition or dependable evidence base.

Galen Growth began operating in 2016. Its early work focused on defining the digital health ecosystem, classifying ventures consistently, and documenting investment, evidence, partnership, and market activity across regions.

Milestones

How the research developed

2016–2018

Building the foundation

The team established a healthcare-specific taxonomy and began assembling structured records on digital health ventures and ecosystems.

2019–2021

Adding evidence and market signals

Research expanded beyond funding to include scientific evidence, commercial relationships, maturity, and other signals needed to compare companies and markets.

2022–2024

Publishing comparative analysis

Galen Growth produced global and regional research, the annual HealthTech 250, and analysis used by healthcare, investment, and innovation teams.

2025–present

Tracking a maturing market

Our research examines evidence quality, partnerships, exits, portfolio concentration, and the transition from digital health experimentation to operating infrastructure.

Galen Growth today

Building on the record

Galen Growth continues to publish research, analysis, definitions, and annual market selections. Our historical record gives every new insight context—and our ongoing work tracks where digital health is heading next.